基于卡达诺的脂类类似物对Trichomonas vaginalis的作用
Tatiana Guinancio de Souza1, Brenda de Lucena Costa2, Cleonice Andrade Holanda2
1Universidade Do Grande Rio, Duque de Caxias, Brazil; Laboratório de Ultraestrutura Celular Hertha Meyer, Centro de Pesquisa Em Medicina de Precisão, Universidade Federal Do Rio de Janeiro, 21941-901, Rio de Janeiro, Brazil; Instituto Nacional de Ciência e Tecnologia and Centro Nacional de Biologia Estrutural e Bioimagem, Universidade Federal Do Rio de Janeiro, Rio de Janeiro, Brazil.
Experimental parasitology
|September 12, 2024
概括
新的卡达诺基基化合物LDT117和LDT134在治疗三虫病方面表现出有前途的表现,因为它们对Trichomonas vaginalis表现出活性,并诱导细胞死亡. 这些化合物对人类上皮细胞无毒,表明潜在的治疗应用.
科学领域:
- 寄生虫学的寄生虫学
- 药用化学 医学化学
- 细胞生物学 细胞生物学
背景情况:
- 阴道三虫 (Trichomonas vaginalis) 引起人类三虫病,这是一种广泛的性传播感染,对健康有重大影响,包括不孕症和对艾滋病毒和癌症的敏感性增加.
- 目前使用美尼达 (MTZ) 的治疗受限于关于怀孕使用和新兴药物耐药性的数据.
- 对于新型治疗药物来对抗三病的需求非常大.
研究的目的:
- 调查基于卡达诺的新型脂类类似物LDT117和LDT134对Trichomonas vaginalis的疗效.
- 评估这些化合物的对人类上皮细胞的毒性.
- 阐明这些化合物对T. vaginalis的作用机制.
主要方法:
- 在体外对LDT117和LDT134进行针对T. vaginalis的测试,确定IC50值.
- 使用人类上皮细胞在培养中的细胞毒性测定.
- 通过扫描和传输电子显微镜进行形态分析.
- 使用TUNEL试验检测细胞亡.
主要成果:
- LDT117和LDT134对T. vaginalis表现出强烈的活性,IC50值分别为4.58微米和10.24微米.
- 这些化合物对培养的上皮细胞没有表现出任何毒性.
- 显微镜检测显示了显著的细胞变化,包括膜损伤和细胞质真空化.
- 道测试表明,这些化合物通过一种类似于亡的机制诱导细胞死亡.
结论:
- 基于卡达诺的化合物LDT117和LDT134在体外对Trichomonas vaginalis有效.
- 这些化合物具有良好的安全性,对宿主上皮细胞无毒.
- 进一步的体内研究是有必要的,以评估它们对人类三虫病的治疗潜力.
相关概念视频
01:18Surface Membrane Barriers
1.1K
The skin and mucous membranes serve as the primary line of defense against pathogens by providing both physical and chemical protection. These barriers are essential in preventing the entry and establishment of microbes, thereby maintaining the integrity of the host.
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...
1.1K
01:25Antianginal Drugs: Calcium Channel Blockers and Ranolazine
464
Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
464